A small study that included 93 children found adalimumab was a safe and effective treatment for moderate to severe ulcerative colitis, researchers reported at UEG Week. Dr. Nicholas Croft said the study showed children achieved clinically meaningful rates of remission and response.
Pediatric study shows adalimumab effective for UC
Sign up for ACG SmartBrief
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.